GALNT7 and prostate carcinoma: These data are consistent with the recent finding that GALNT7 is a single gene effector of cell surface glycosylation and glycocalyx height [23], and suggest GALNT7 mediated O-glycosylation may act at the interface of important signalling pathways in prostate cancer cells to promote disease progression.